Cutler Group’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-60
Closed -$4K 6336
2020
Q4
$4K Hold
60
﹤0.01% 3842
2020
Q3
$4K Sell
60
-60
-50% -$4.81K ﹤0.01% 3719
2020
Q2
$8K Sell
120
-173
-59% -$13.6K ﹤0.01% 3051
2020
Q1
$16K Buy
+293
New +$20.4K ﹤0.01% 2463
2019
Q4
Sell
-13
Closed 4631
2019
Q3
$0 Buy
+13
New +$873 ﹤0.01% 4752
2018
Q4
Sell
-700
Closed -$80.9K 4626
2018
Q3
$84K Sell
700
-300
-30% -$37.2K 0.01% 1302
2018
Q2
$115K Buy
1,000
+600
+150% +$65.6K 0.01% 1064
2018
Q1
$34K Buy
+400
New +$31K ﹤0.01% 1931
2017
Q4
Sell
-2,469
Closed -$165K 5984
2017
Q3
$142K Buy
2,469
+2,268
+1,128% +$134K 0.01% 1402
2017
Q2
$12K Buy
+201
New +$12.4K ﹤0.01% 4000

Other funds holding USNA

Cutler Group's USNA Position: Q1 2021 in Review

Cutler Group sold out of Usana Health Sciences (USNA) in Q1 2021, closing a stake of 60 shares — an estimated $4K sold.

Cutler Group first reported a position in USNA in Q2 2017 and held it in 10 quarters. The position peaked at $142K in Q3 2017. 198 funds tracked by Wall St. Rank hold USNA as of Q1 2021.

  • Cutler Group reported no remaining Usana Health Sciences position as of Q1 2021 after selling out during the quarter.
  • Cutler Group sold 60 Usana Health Sciences shares in Q1 2021, an estimated $4K.
  • Cutler Group first reported a position in Usana Health Sciences in Q2 2017 and held it in 10 quarters.
  • Cutler Group's Usana Health Sciences position peaked at $142K in Q3 2017.
  • 198 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2021.

Based on Cutler Group's 13F filing for Q1 2021, filed 26 Apr 2021.